Cargando…

Type 2 diabetes and the clinically normal pulp: An in vitro study

AIM: The aim of this study was to investigate the effect of type 2 diabetes (T2D) on clinically normal dental pulp tissue by using special stains and immunohistochemistry (IHC) to determine the morphology of the coronal pulp and distribution of immune markers in non‐T2D and T2D groups. METHODOLOGY:...

Descripción completa

Detalles Bibliográficos
Autores principales: Alsamahi, Shaikhah, Milne, Trudy M., Hussaini, Haizal, Rich, Alison M., Friedlander, Lara T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9324782/
https://www.ncbi.nlm.nih.gov/pubmed/35322881
http://dx.doi.org/10.1111/iej.13732
_version_ 1784756883680133120
author Alsamahi, Shaikhah
Milne, Trudy M.
Hussaini, Haizal
Rich, Alison M.
Friedlander, Lara T.
author_facet Alsamahi, Shaikhah
Milne, Trudy M.
Hussaini, Haizal
Rich, Alison M.
Friedlander, Lara T.
author_sort Alsamahi, Shaikhah
collection PubMed
description AIM: The aim of this study was to investigate the effect of type 2 diabetes (T2D) on clinically normal dental pulp tissue by using special stains and immunohistochemistry (IHC) to determine the morphology of the coronal pulp and distribution of immune markers in non‐T2D and T2D groups. METHODOLOGY: Ethics approval for this in vitro pilot study was obtained from the University of Otago Human Ethics Committee (16/069). Twenty extracted permanent molar teeth diagnosed as having clinically normal pulp status were collected. Ten teeth were from participants with well‐controlled T2D and ten from participants without diabetes (non‐T2D). Each tooth was sectioned transversely at the cemento‐enamel junction before the crowns were decalcified and embedded in paraffin. Sections were stained with haematoxylin and eosin, Massons trichrome, and van Gieson stains for histological and morphological evaluation. IHC using anti‐CD4, anti‐CD68 and anti‐CD83 and anti‐IL1β, anti‐IL6, anti‐IL17, anti‐TNF‐α, anti‐TLR2, anti‐TLR4 and anti‐FOXP3 identified proteins of interest. Qualitative and semi‐quantitative analyses evaluated the morphology of the dental pulp and protein expression. Data analyses were performed with GraphPad Prism, using Student's t‐test and multiple regression using SPSS at p < .05. RESULTS: Special stains demonstrated morphological differences in the T2D dental pulp compared with non‐T2D. Qualitative analysis indicated that the pulp in the T2D samples was consistently less cellular, less vascular, showed evidence of thickened blood vessel walls, increased pulp calcification and collagen deposition. Semi‐quantitative analysis of IHC samples showed the T2D pulp had significantly increased expression of macrophage and dendritic cell markers CD68 (p < .001) and CD83 (p = .04), and there was significantly greater expression of inflammatory cytokines IL1β (p = .01), IL6 (p < .0001), IL17 (p < .0001) and TNF‐α (p = .01). T2D samples showed a significant increase in markers of innate inflammation, TLR2 (p < .001) and TLR4 (p < .001) and decreased expression of regulatory T‐cell marker, FOXP3 (p = .01). Multiple regression showed that age‐corrected differences were statistically significant. CONCLUSION: Preliminary findings suggest that T2D may exert a similar response in the pulp to complications in other body sites. Hyperglycaemia is associated with changes in the morphology of the clinically normal dental pulp with altered immune cell and cytokine expression.
format Online
Article
Text
id pubmed-9324782
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-93247822022-07-30 Type 2 diabetes and the clinically normal pulp: An in vitro study Alsamahi, Shaikhah Milne, Trudy M. Hussaini, Haizal Rich, Alison M. Friedlander, Lara T. Int Endod J Biological Research AIM: The aim of this study was to investigate the effect of type 2 diabetes (T2D) on clinically normal dental pulp tissue by using special stains and immunohistochemistry (IHC) to determine the morphology of the coronal pulp and distribution of immune markers in non‐T2D and T2D groups. METHODOLOGY: Ethics approval for this in vitro pilot study was obtained from the University of Otago Human Ethics Committee (16/069). Twenty extracted permanent molar teeth diagnosed as having clinically normal pulp status were collected. Ten teeth were from participants with well‐controlled T2D and ten from participants without diabetes (non‐T2D). Each tooth was sectioned transversely at the cemento‐enamel junction before the crowns were decalcified and embedded in paraffin. Sections were stained with haematoxylin and eosin, Massons trichrome, and van Gieson stains for histological and morphological evaluation. IHC using anti‐CD4, anti‐CD68 and anti‐CD83 and anti‐IL1β, anti‐IL6, anti‐IL17, anti‐TNF‐α, anti‐TLR2, anti‐TLR4 and anti‐FOXP3 identified proteins of interest. Qualitative and semi‐quantitative analyses evaluated the morphology of the dental pulp and protein expression. Data analyses were performed with GraphPad Prism, using Student's t‐test and multiple regression using SPSS at p < .05. RESULTS: Special stains demonstrated morphological differences in the T2D dental pulp compared with non‐T2D. Qualitative analysis indicated that the pulp in the T2D samples was consistently less cellular, less vascular, showed evidence of thickened blood vessel walls, increased pulp calcification and collagen deposition. Semi‐quantitative analysis of IHC samples showed the T2D pulp had significantly increased expression of macrophage and dendritic cell markers CD68 (p < .001) and CD83 (p = .04), and there was significantly greater expression of inflammatory cytokines IL1β (p = .01), IL6 (p < .0001), IL17 (p < .0001) and TNF‐α (p = .01). T2D samples showed a significant increase in markers of innate inflammation, TLR2 (p < .001) and TLR4 (p < .001) and decreased expression of regulatory T‐cell marker, FOXP3 (p = .01). Multiple regression showed that age‐corrected differences were statistically significant. CONCLUSION: Preliminary findings suggest that T2D may exert a similar response in the pulp to complications in other body sites. Hyperglycaemia is associated with changes in the morphology of the clinically normal dental pulp with altered immune cell and cytokine expression. John Wiley and Sons Inc. 2022-04-01 2022-06 /pmc/articles/PMC9324782/ /pubmed/35322881 http://dx.doi.org/10.1111/iej.13732 Text en © 2022 The Authors. International Endodontic Journal published by John Wiley & Sons Ltd on behalf of British Endodontic Society. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Biological Research
Alsamahi, Shaikhah
Milne, Trudy M.
Hussaini, Haizal
Rich, Alison M.
Friedlander, Lara T.
Type 2 diabetes and the clinically normal pulp: An in vitro study
title Type 2 diabetes and the clinically normal pulp: An in vitro study
title_full Type 2 diabetes and the clinically normal pulp: An in vitro study
title_fullStr Type 2 diabetes and the clinically normal pulp: An in vitro study
title_full_unstemmed Type 2 diabetes and the clinically normal pulp: An in vitro study
title_short Type 2 diabetes and the clinically normal pulp: An in vitro study
title_sort type 2 diabetes and the clinically normal pulp: an in vitro study
topic Biological Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9324782/
https://www.ncbi.nlm.nih.gov/pubmed/35322881
http://dx.doi.org/10.1111/iej.13732
work_keys_str_mv AT alsamahishaikhah type2diabetesandtheclinicallynormalpulpaninvitrostudy
AT milnetrudym type2diabetesandtheclinicallynormalpulpaninvitrostudy
AT hussainihaizal type2diabetesandtheclinicallynormalpulpaninvitrostudy
AT richalisonm type2diabetesandtheclinicallynormalpulpaninvitrostudy
AT friedlanderlarat type2diabetesandtheclinicallynormalpulpaninvitrostudy